Navigation Links
Ventas Appoints James D. Shelton and Robert D. Reed to Board
Date:3/5/2008

LOUISVILLE, Ky., March 5 /PRNewswire-FirstCall/ -- Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") said today that James "Denny" Shelton and Robert D. Reed have been appointed to its Board of Directors, effective immediately. Shelton is Chairman of Legacy Hospital Partners, Inc., and most recently was the Chairman and Chief Executive Officer for Triad Hospitals, Inc. Reed is Senior Vice President and Chief Financial Officer for Sutter Health.

"The addition of Denny and Bob to the Ventas Board continues our focus on excellence. These highly respected hospital executives will bring significant operating and financial experience and insights to the Ventas Board," Ventas Chairman, President and Chief Executive Officer Debra A. Cafaro said. "As we focus on expanding our medical office building business and on meeting the growing needs of not-for-profit and investor owned hospital systems, their industry knowledge will greatly enhance our efforts."

Shelton is Chairman of the Board of Legacy Hospital Partners, Inc. ("Legacy"), a privately held company that will own, operate and manage acute care hospitals in small cities and select urban markets throughout the United States. Headquartered in Plano, Texas, and established in January 2008, Legacy is owned by affiliates of private equity firm CCMP Capital Advisors, LLC and the Canada Pension Plan Investment Board, as well as members of management. Shelton was the founder, Chairman and Chief Executive Officer of Triad Hospitals, Inc. until the organization was sold in 2007. Shelton is also a director of Omnicare, Inc. (NYSE: OCR) and the non-profit organization Health Coverage Foundation, a group organized to promote private solutions for the medically uninsured in America. He also
'/>"/>

SOURCE Ventas, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Ventas to Present at the Citi 2008 Global Property CEO Conference
2. Ventas Reports Ten Percent Rise in 2007 Normalized FFO Per Common Share to $2.69
3. Ventas Completes Previously Announced Sale of Common Stock
4. Ventas Enters Agreement to Sell Common Stock
5. Ventas Grants Stock Awards to Promote Long-Term Retention and Reward Performance
6. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
7. Ventas Appoints Brush SVP - Senior Housing Development and Operations
8. Ventas Announces 2007 Third Quarter Earnings Release Date and Conference Call
9. Ventas Board Names Ronald G. Geary Audit Committee Chair; Appoints Douglas Crocker II to Fill Vacancy on Audit Committee
10. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
11. Crdentia Appoints Randall Turnbull to Senior Vice President and Chief Clinical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... United States Vice President Dick Cheney served as the ... , In front of 1,500 guests yesterday at ... "I am delighted to be here to have the ... Year Award. I think it's a tremendous recognition; I ... company like this because there are obviously a great ...
(Date:5/23/2013)... Spring and summer have always been motivation for people to ... city between Memphis and Nashville? In the last year alone, ... transformed the growing area into one of the most health-conscious ... vibrant, young professionals you are going to see demand for ... of The Fight Shop, one of the city’s hottest new ...
(Date:5/23/2013)... On April 29th, 2013, UV Technologies ... numbers of H7N9 cases and deaths. The headline read, " ... Will Subside in Northern Hemisphere as Available Daylight Increases .” ... been reported. , Quoting Kevin McGuire, president of UV ... flowers budding in the spring and leaves changing in the ...
(Date:5/23/2013)... York (PRWEB) May 23, 2013 Parker ... the rights of victims injured by defective medical devices ... Counsel Matthew J. McCauley has been appointed Co-Lead Counsel ... Mirena IUD Products Liability Litigation (Case 7:13-md-02434-CS). The Order, ... and Liaison Counsel are to submit their proposal for ...
(Date:5/23/2013)... EnvirOasis, the leader in energy efficient lighting ... pleased to announce its new line of Energy Star ... EnvirOasis has been a market leader in Fluorescent and ... has recently brought to market a full line of ... energy efficient lighting technology which produces a very high ...
Breaking Medicine News(10 mins):Health News:Acadian Ambulance Honors Paramedic of the Year at Annual Luncheon 2Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 2Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 3Health News:Grass Roots Wellness Initiative Builds Muscle in Jackson, Tennessee 4Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 2Health News:UV Technologies Bold Prediction on H7N9 in China Comes True, New Cases End Without Aid of Flu Vaccine 3Health News:U.S. District Court Appoints Parker Waichman LLP’s Matthew J. McCauley to Leadership Role in Mirena IUD Litigation 2Health News:EnvirOasis Lighting Announces Energy Star and Design Lights Consortium LED Products 2
... of Advanced Nursing reports that many socially disadvantaged UK residents ... . ,A research across London by TB specialists ... trying to halt the spread of the disease. ... last 10 years and London is no exception" says lead ...
... seem to be becoming ever more hectic. With the result ... Australian children in the 10-15 year age group tend ... when compared with just one generation ago. ,Increased ... are to blame, with adolescents no longer adhering to 'lights ...
... State University held a prayer and yoga session during the ... friendship and a lot of learning together," said Kanchan Banerjee, ... after the event Saturday. ,It has been 17 ... ,More than 30 students sat barefoot and cross-legged and chanted ...
... researchers have concluded that almost 60 percent of Nebraska ... water bodies were declared impaired by federal and state ... method of testing was more conclusive in pinpointing the ... Effective pollution-control strategies can be developed only if researchers ...
... President Bush might make a show of laying wreaths on ... in the war on terror. ,But post traumatic stress disorder ... Families of veterans have begun to speak out, complaining that ... ,In the three months after Marine Maj. John Ruocco returned ...
... mini-couch potatoes, for a new study has found that kids ... chronic health problems in later life. ,As a ... examined activity levels of more than 3,500 students from five ... half of the kids hardly got any exercise, for they ...
Cached Medicine News:Health News:TB Patients in Marginalised Groups Need Social Support for Effective Medical Treatment 2Health News:Australian Children Sleep Less, Perhaps Not Well Monitored 2Health News:Fecal Bacteria, a Source of Contamination 2Health News:Suicide Among Returning US Soldiers on the Rise 2Health News:Suicide Among Returning US Soldiers on the Rise 3Health News:Suicide Among Returning US Soldiers on the Rise 4
(Date:5/23/2013)... THOUSAND OAKS, Calif. , May 23, 2013 ... Deutsche Bank 38 th Annual  Healthcare Conference on Thursday, ... Boston , beginning at 9:20 a.m. Eastern Daylight ... Investor Relations at Amgen, will present at the conference. Live ... Calendar on Amgen,s website, www.amgen.com , under Investors. A ...
(Date:5/23/2013)... Minn. , May 23, 2013  MGC Diagnostics ... a global medical technology company, today scheduled a conference ... quarter of fiscal year 2013, ended April 30, 2013. ... Thursday, May 30, 2013. The Company will report financial ... after the markets close on Thursday, May 30, 2013. ...
(Date:5/23/2013)... May 23, 2013 More than half of ... benefit from chemotherapy and still have excellent outcomes. To ... one of the largest sources of online consumer information ... interactive Facebook page provide recently diagnosed women with information ... avoid chemotherapy. "We anticipate these innovative social ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3
... MIAMI, FL -- (MARKET WIRE) ... DOR BioPharma,Inc. (OTCBB: <a target="_blank" ... announced today that the European ... EP 1024827 B1, with claims ...
... -- Results from,the primary analysis of a ... 77 percent of treatment-experienced HIV-1,infected adults taking ... ritonavir (PREZISTA/r) twice daily, plus an optimized,background ... a,plasma viral load of <400 copies/mL at ...
Cached Medicine Technology:DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 2DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 3DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 4DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 5DOR BioPharma Announces Issuance of European Patent for Its Oral,Multivalent Botulinum Toxin Vaccine BT-VACC 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8
CURRENT Consult: Surgery brings you authoritative clinical answers on more than 360 surgically treated disorders in the most efficient format, perfectly devised for the busy physician....
Over 10,000 entries. This dictionary is both a home medical guide and as an aid for all those working in the medical and allied professions. The entries are laid out and jargon-free....
... Tabers Cyclopedic Medical Dictionary ... Medical Wizards and based on ... now available on PDA. It ... for nurses and health-care professionals, ...
This portable resource provides definitions for medical acronyms and abbreviations....
Medicine Products: